Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 12 mil bid US

<< Previous

Bullboard Posts

Next >>

Comment by Tcwtaeugene2on Feb 05, 2024 12:47pm

138 Views

Post# 35863332

RE:12 mil bid US

Better go to the official O.T.C. market site to have the real bids and asks. For me, this is more 14K bid. on the ask. You have to retreive the 2 or 3 lasts digits. This is not a market platform so errors can occur.

E Good luck

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading